NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation
Your view on NMTC
Overview
What the company does, where it operates, and who runs it.
About NeuroOne Medical Technologies Corporation
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David A. Rosa
- Headquarters
- 7599 Anagram Drive, Eden Prairie, MN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David A. Rosa
- Headquarters
- 7599 Anagram Drive, Eden Prairie, MN, US
NeuroOne Medical Technologies Corporation operates as a medical technology company.
The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.
It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for NeuroOne Medical Technologies Corporation, and the rating behind it. NMTC last traded at $1.56; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for NeuroOne Medical Technologies Corporation. Starting points for NeuroOne Medical Technologies Corporation: EPS -$0.83, beta 0.64 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for NeuroOne Medical Technologies Corporation. NeuroOne Medical Technologies Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for NeuroOne Medical Technologies Corporation. Trailing twelve-month EPS for NeuroOne Medical Technologies Corporation stands at -$0.83. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for NeuroOne Medical Technologies Corporation. NeuroOne Medical Technologies Corporation has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
NeuroOne Medical Technologies Corporation valued side by side against its closest peers. NeuroOne Medical Technologies Corporation is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold NeuroOne Medical Technologies Corporation, and how their positions are changing. At a $13.6M market value, institutional positions materially move NeuroOne Medical Technologies Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by NeuroOne Medical Technologies Corporation executives and directors. Shares of NeuroOne Medical Technologies Corporation have traded between $0.40 and $1.39 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming NeuroOne Medical Technologies Corporation. NeuroOne Medical Technologies Corporation is a $13.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming NeuroOne Medical Technologies Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for NeuroOne Medical Technologies Corporation. Coverage tracks NeuroOne Medical Technologies Corporation within Medical - Devices (Healthcare). Press releases and market coverage, newest first.